stockrow
Saturday 7 November 2026
Export PARK’s income statement to Excel — free account
Park Dental Partners, Inc.
PARK Healthcare Medical Care Facilities
Park Dental Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $244.5 million, up 6.40% from fiscal 2024.
- Revenue
- +12.2%
- EPS
- −65.8%
- Free cash flow
- −34.8%
Quarter to June 2026, against a year earlier
20.63
0.49
+2.43%
Follow PARK
Alert me
| Jun '26 | Mar '26 | Dec '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+2 more quarters Free account |
P/S ratio |
0.39 | 0.30 | 0.00 | 0.00 | |
P/FCF ratio |
5.79 | 4.04 | 2.37 | 0.00 | |
P/Operating CF |
21.00 | 14.63 | 2.08 | 5.39 | |
P/B ratio |
3.30 | 2.89 | 1.68 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.34 | 0.25 | 0.00 | 0.00 | |
EV/EBITDA |
1.19 | 0.83 | 0.00 | 0.00 | |
EV/Operating CF |
2.77 | 1.90 | 0.87 | 0.00 | |
EV/FCF |
5.00 | 3.33 | 1.52 | 0.00 | |
Quick Ratio |
1.00 | 0.96 | 0.98 | — | |
Current Ratio |
1.12 | 1.07 | 1.06 | — | |
Net Debt/EBITDA |
(3.71) | (25.58) | (0.22) | 0.00 | |
Debt/Assets |
5.92% | 6.40% | 6.72% | 0.00% | |
Debt/Equity |
0.37 | 0.45 | 0.55 | 0.00 | |
Asset Turnover |
2.72 | 1.50 | — | — | |
Operating CF/Net income |
3.48 | (12.89) | (3.07) | 1.31 | |
Capex/Depreciation |
(1.04) | (0.97) | (0.78) | (0.68) | |
Interest Coverage |
9.18 | (15.54) | — | 12.43 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
11.83% | 12.50% | 0.00% | 11.71% | |
Intangible Assets out of Total Assets |
0.16 | 0.17 | 0.16 | 0.00 | |
Share Based Compensation of Revenue |
4.58% | 6.42% | 0.00% | 0.00% | |
Graham Net Nets |
(1.19) | (1.59) | (3.23) | (7.74) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(3.02%) | (0.43%) | (0.43%) | (0.43%) | |
Free Cash Flow Yield |
17.28% | 24.78% | 42.23% | 0.00% | |
Revenue per Share |
14.48 | 14.30 | 24.61 | 35.54 | |
Operating CF per Share |
1.03 | 1.15 | 7.09 | 1.90 | |
Capex per Share |
(0.54) | (0.53) | (2.95) | (0.90) | |
Free Cash Flow per Share |
0.49 | 0.62 | 4.14 | 1.00 | |
Cash per Share |
5.34 | 5.56 | 10.13 | 0.00 | |
Shareholders Equity per Share |
6.52 | 5.80 | 8.77 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.52 | 5.80 | 8.77 | 0.00 | |
Free Cash Flow |
2.24 | 2.72 | 10.29 | 1.77 | |
Working Capital |
4.35 | 2.42 | 2.17 | — | |
Capital Expenditures |
(2.45) | (2.30) | (7.34) | (1.60) | |
Net Current Asset Value |
(116.80) | (116.70) | (118.48) | 0.00 | |
EV/EBIT |
1.32 | 0.92 | 0.00 | 0.00 | |
Capex to Sales |
0.04 | 0.04 | 0.12 | 0.03 | |
Price to Operating Income |
1.52 | 1.11 | 0.00 | 0.00 | |
| Other line items | |||||
Average Assets |
93.13 | 164.36 | — | — |
Columns are period end dates